Biomea Fusion (BMEA)
(Real Time Quote from BATS)
$4.56 USD
-0.65 (-12.48%)
Updated Jun 26, 2024 02:12 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Income Statements
Fiscal Year end for Biomea Fusion, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 126 | 84 | 42 | 5 | 1 |
Income After Depreciation & Amortization | -126 | -84 | -42 | -5 | -1 |
Non-Operating Income | 9 | 2 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -117 | -82 | -42 | -5 | -1 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -117 | -82 | -42 | -5 | -1 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -117 | -82 | -42 | -5 | -1 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -125 | -83 | -41 | -5 | -1 |
Depreciation & Amortization (Cash Flow) | 2 | 1 | 1 | 0 | 0 |
Income After Depreciation & Amortization | -126 | -84 | -42 | -5 | -1 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 34.11 | 29.27 | 23.86 | NA | NA |
Diluted EPS Before Non-Recurring Items | -3.44 | -2.80 | -1.74 | NA | NA |
Diluted Net EPS (GAAP) | -3.44 | -2.80 | -1.74 | NA | NA |
Fiscal Year end for Biomea Fusion, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 41.06 | 37.33 | 31.12 | 27.66 | 30.04 |
Income After SG&A, R&D, and Dept/Amort Expenses | -41.06 | -37.33 | -31.12 | -27.66 | -30.04 |
Non-Operating Income | 2.00 | 2.44 | 2.69 | 2.77 | 0.98 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -39.06 | -34.88 | -28.43 | -24.89 | -29.05 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -39.06 | -34.88 | -28.43 | -24.89 | -29.05 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -39.06 | -34.88 | -28.43 | -24.89 | -29.05 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 35.89 | 35.75 | 35.65 | 35.35 | 29.59 |
Diluted EPS Before Non-Recurring Items | -1.09 | -0.98 | -0.80 | -0.70 | -0.98 |
Diluted Net EPS (GAAP) | -1.09 | -0.96 | -0.80 | -0.70 | -0.98 |